SHMT2 and neoplasm: Immunohistochemistry also showed lower expression levels of stemness markers, Notch-related, and Wnt-related genes, including HES1 and CYCLIN D1, in the SHMT2-deficient tumor groups than in the control tumor group (Figure 6G).